Breaking bad news–what patients want and what they get: evaluating the SPIKES protocol in Germany
Seifart, C., Hofmann, M., Bär, T., Riera Knorrenschild, J., Seifart, U., Rief, W.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
Maurer, Elisabeth, Eilsberger, F., Wächter, S., Riera Knorrenschild, J., Pehl, A., Holzer, K., Neubauer, A., Luster, M., Bartsch, D. K.
Published in European archives of oto-rhino-laryngology (01.03.2023)
Published in European archives of oto-rhino-laryngology (01.03.2023)
Get full text
Journal Article
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
Thomas, M., Ponce-Aix, S., Navarro, A., Riera-Knorrenschild, J., Schmidt, M., Wiegert, E., Kapp, K., Wittig, B., Mauri, C., Dómine Gómez, M., Kollmeier, J., Sadjadian, P., Fröhling, K -P, Huber, R.M., Wolf, M., Pall, Georg, Surmont, Veerle, Bosquee, Léon, Germonpré, Paul, Brückl, Wolfgang, Grah, Christina, Herzmann, Christian, Leistner, Rumo, Meyer, Andreas, Müller, Lothar, Schmalz, Oliver, Scholz, Christian, Schröder, Michael, Serke, Monika, Wesseler, Claas, Brandts, Christian, Kopp, Hans-Georg, Blau, Wolfgang, Griesinger, Frank, Campelo, Maria Rosario Garcia, Garcia, Yolanda Garcia, Perez, José Manuel Trigo
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1st-line mFOLFOXIRI + panitumumab vs FOLFOXIRI treatment of RAS wt mCRC: A randomized phase II VOLFI trial of the AIO (KRK-0109)
Geissler, M, Klingler, T, Riera Knorrenschild, J, Tannapfel, A, Greeve, J, Seufferlein, T, Kanzler, S, Held, S, Heinemann, V, Reinacher-Schick, A, Martens, U M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
Kurreck, A., Geissler, M., Martens, U. M., Riera-Knorrenschild, J., Greeve, J., Florschütz, A., Wessendorf, S., Ettrich, T., Kanzler, S., Nörenberg, D., Seidensticker, M., Held, S., Buechner-Steudel, P., Atzpodien, J., Heinemann, V., Stintzing, S., Seufferlein, T., Tannapfel, A., Reinacher-Schick, A. C., Modest, D. P.
Published in Journal of cancer research and clinical oncology (01.10.2020)
Published in Journal of cancer research and clinical oncology (01.10.2020)
Get full text
Journal Article
Maintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study
Thomas, M., Ponce Aix, S., Navarro Mendivil, A., Riera Knorrenschild, J., Schmidt, M., Wiegert, E., Kapp, K., Mauri, C., Domine Gomez, M., Kollmeier, J., Sadjadian, P., Fröhling, K.-P., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
PD-005Response and resistance factor candidates to HER2 targeted therapy in gastric cancer (GC)
Lordick, F, Haffner, I, Luber, B, Maier, D, Kretzschmar, A, Fischer von Weikersthal, L, Riera-Knorrenschild, J, Ahlborn, M, Schierle, K, Wittekind, C
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study
Scheithauer, W, Riera-Knorrenschild, J, Kopp, H.G, Mayer, F, Kroening, H, Nitsche, D, Kuhlmann, J, Ziebermayr, R, Andel, J, Arnold, D, Zurlo, A, Wittig, B, Schmoll, H.J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: First results of a randomized phase III trial
Stahl, M., Walz, M. K., Stuschke, M., Lehmann, N., Seegenschmiedt, M. H., Riera Knorrenschild, J., Langer, P., Bieker, M., Königsrainer, A., Budach, W., Wilke, H.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
424P Pembrolizumab and olaparib in advanced HER2-negative esophagogastric adenocarcinoma: First results of the phase II AIO IKF-038/POLESTAR trial
Haag, G.M., Goetze, T.O., Thuss-Patience, P.C., Knorrenschild, J. Riera, Lorenzen, S., Homann, N., Ettrich, T.J., Walle, T., Stenzinger, A., Brobeil, A., Schaaf, M., Pauligk, C., Al-Batran, S-E., Stein, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
106P Ultra low-coverage whole genome sequencing for precision oncology in solid tumors
Tarawneh, T.S., Rodepeter, F., Ross, P., Teply-Szymanski, J., Koch, V., Thölken, C., Riera Knorrenschild, J., Wündisch, T., Denkert, C., Neubauer, A., Mack, E.
Published in Annals of oncology (01.10.2022)
Published in Annals of oncology (01.10.2022)
Get full text
Journal Article
580P - Quality of life during 1st-line FOLFOXIRI+/- panitumumab in RAS wild-type metastatic colorectal cancer: Results from the randomized VOLFI trial (AIO KRK-0109)
Geissler, M., Klingler, T., Modest, D., Knorrenschild, J Riera, Ettrich, T.J., Kanzler, S., Heinemann, V., Held, S., Martens, U.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Quality of life during 1st-line FOLFOXIRI+/- panitumumab in RAS wild-type metastatic colorectal cancer: Results from the randomized VOLFI trial (AIO KRK-0109)
Geissler, M., Klingler, T., Modest, D., Knorrenschild, J Riera, Ettrich, T.J., Kanzler, S., Heinemann, V., Held, S., Martens, U.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
680P HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany
Langer, C., von der Heyde, E., Hahn, D.A., Kubuschok, B., Bockmühl, U., Mueller-Huesmann, H., Klautke, G., von der Grün, J., Beutner, D., Büntzel, J., Busch, C-J., Tamaskovics, B.F., Riera Knorrenschild, J., Gutsche, K., Welslau, M.K., Gauler, T.C., Waldenberger, D., Dietz, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1216P Prognostic potential of liquid biopsy in advanced HER2 positive esophagogastric adenocarcinoma under HER2 blockade and immune checkpoint therapy
Paschold, L., Stein, A., Henkes, S., Tintelnot, J., Goekkurt, E., Simnica, D., Schultheiß, C., Willscher, E., Bauer, M., Wickenhauser, C., Thuss-Patience, P.C., Lorenzen, S., Riera Knorrenschild, J., Kubicka, S., Reinacher-Schick, A., Sinn, M., Hiegl, W., Hinke, A., Hegewisch-Becker, S., Binder, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
Lorenzen, S., Thuss-Patience, P.C., Folprecht, G., Riera Knorrenschild, J., Heinemann, V., Goekkurt, E., Dechow, T.N., Ettrich, T.J., Luley, K.B., Moulin, J-C., Lindig, U., Angermeier, S., Waidmann, O., Pink, D., Bolling, C., Junge, S., Pauligk, C., Gaiser, T., Götze, T.O., Al-Batran, S-E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
580PQuality of life during 1st-line FOLFOXIRI+/- panitumumab in RAS wild-type metastatic colorectal cancer: Results from the randomized VOLFI trial (AIO KRK-0109)
Geissler, M, Klingler, T, Modest, D, Knorrenschild, J Riera, Ettrich, T J, Kanzler, S, Heinemann, V, Held, S, Martens, U M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article